Bayer CropScience and Chromatin Inc. launch mini-chromosome technology alliance
Bayer CropScience and chromatin Inc. announced that they have entered into a technological alliance and license agreement to use Chromatin’s proprietary mini-chromosome technology for crop improvement.
Chromatin has developed a novel approach to gene stacking, using plant DNA to deliver several genes on a single chromosome. Under the agreement, Bayer CropScience has obtained non-exclusive rights to use Chromatin’s technology to introduce Bayer’s high-value trait genes into cotton. Bayer CropScience also obtained options to expand this program to other crops. Further terms of the deal were not disclosed.
Dr. Linda Trolinder, Global Cotton R&D Manager at BioScience, a business operations unit of Bayer CropScience, welcomes the new business relationship with Chromatin: "Bayer CropScience is committed to offering top-of-the-line innovation to its customers, and Chromatin's technology enables the use of new approaches and more flexibility in research which will facilitate the speed with which we bring our products to customers.”
Other news from the department business & finance
Most read news
More news from our other portals
Last viewed contents
IXICO and PsiOxus Therapeutics win significant funding from government-backed Biomedical Catalyst
Novartis gains exclusive rights to Debio 025, an antiviral agent as potential first-in-class hepatitis C therapy - Novartis to make upfront payment to Debiopharm Group, with Debiopharm eligible for milestones and royalties on future sales
Merck & Co. Announces New Name for its Animal Health Division
PolyTherics appoints new Chairman
Germany Begins its First AIDS Vaccine Trial, Partnering with IAVI
MedImmune to Collaborate With National Institutes of Health to Develop Pandemic Influenza Vaccine
Pharmexa presents data from influenza program
Dental_public_health
